| Rubicon Water Limited (RWL) ORDINARY FULLY PAID |
Information Technology |
$31 |
1H26 Appendix 4D and Half Year Report
|
27 Feb 2026 9:33AM |
$0.180 |
$0.130 |
fallen by
27.78%
|
|
RWL - Price-sensitive ASX Announcement
Full Release
Key Points
- Rubicon Water Limited reported a net loss after tax of $6,390,000 for the six months ended 31 December 2025.
- Revenue for the first half of 2025 was $29,022,000, down from $32,018,000 in the same period of 2024.
- The most significant revenue decline occurred in the ANZ segment, primarily due to decreased hardware and spare parts sales.
- Underlying EBITDA was a loss of $5,854,000, compared to a loss of $1,694,000 in the previous year.
- Rubicon Water Limited did not declare or pay any dividends during the reporting period.
- Net tangible assets per ordinary security decreased from $0.27 in 2024 to $0.21 in 2025.
- Exchange rate fluctuations contributed to a $2.1 million negative impact year-on-year due to a stronger Australian dollar.
- The Asia segment is expected to recover in the second half of the year with increased project activity.
- The company has joint ventures, including Medha Rubicon Water Technologies Pvt Ltd, in which it holds a 50% ownership interest.
- No significant events occurred after the reporting date that would impact the financial statements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$63 |
Application for quotation of securities - NUZ
|
27 Feb 2026 9:32AM |
$0.100 |
$0.085 |
fallen by
15%
|
|
| HeraMED Limited (HMD) ORDINARY FULLY PAID |
Health Care |
$57 |
Annual Report to shareholders
|
27 Feb 2026 9:32AM |
$0.036 |
$0.049 |
risen by
36.11%
|
|
| Alpha HPA Limited (A4N) ORDINARY FULLY PAID |
Materials |
$907 |
Application for quotation of securities - A4N
|
27 Feb 2026 9:32AM |
$0.650 |
$0.625 |
fallen by
3.85%
|
|
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$6 |
Appendix 4D and Half Year Financial Report
|
27 Feb 2026 9:32AM |
$0.081 |
$0.062 |
fallen by
23.46%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax for the half-year: $3,565,836
- Total assets as of 31 December 2025: $8,088,461
- Net assets as of 31 December 2025: $5,706,180
- No dividends paid or declared during the period
- Convertible notes issued for additional funding
- Significant expenditure on research and development
- PhotosoftTM technology focus and potential Orphan Drug Designation
- R&D tax incentive loan facility secured
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kina Securities Limited (KSL) ORDINARY FULLY PAID |
Financials |
$365 |
FY25 Appendix 4E Preliminary Final Report
|
27 Feb 2026 9:31AM |
$1.235 |
$1.240 |
risen by
0.40%
|
|
KSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Net Profit After Tax increased by 20% to PGK 120.7 million.
- Revenue from ordinary activities rose by 13% to PGK 545.5 million.
- Net interest income increased by 20%.
- Foreign exchange income grew by 17%.
- Unfranked dividends declared at AUD 6.5 cents per share.
- Operating expenses increased by 4%.
- Cost-to-income ratio improved to 54.7%.
- Loans and advances to customers increased by 13%.
- Capital adequacy ratios remained strong at 17.1%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$739 |
2025 Financial Results and Corporate Update
|
27 Feb 2026 9:31AM |
$8.870 |
$7.600 |
fallen by
14.32%
|
|
AVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Initiated global pivotal PARADIGM Trial.
- Favorable 30-day and 1-year outcomes for DurAVR® THV.
- First successful double DurAVR® implant.
- Strengthened operational infrastructure and manufacturing capabilities.
- ISO 13485 certification for DurAVR® THV production.
- Net operating cash outflows of US$77.8 million in 2025.
- R&D expenses totaled US$69.1 million.
- Secured US$320 million in capital raises, including Medtronic investment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Platinum International Fund (Quoted Managed Hedge Fund) (PIXX) |
Financials |
$77 |
2026 Interim Financial Report
|
27 Feb 2026 9:31AM |
$5.050 |
$5.140 |
risen by
1.78%
|
|
| Associate Global Partners Limited (APL) ORDINARY FULLY PAID |
Financials |
$17 |
Investor Presentation February 2026
|
27 Feb 2026 9:30AM |
$0.180 |
$0.300 |
risen by
66.67%
|
|
APL - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive net inflows recorded in H1 FY2026.
- FUM reached $1.42 billion by December 2025.
- WCM product suite contributed significantly to FUM growth.
- Partnership with Switzer Financial Group enhances direct business capabilities.
- Strategic focus on expanding manager partnerships and launching new products.
- Achieved operating profitability in H1 FY26.
- Revenue increased by 10.2% in H1 FY26.
- Net loss reduced by 92.3% in H1 FY26.
- Five consecutive quarters of positive operating cash flow achieved.
- Ongoing initiatives to diversify investor base and drive sustainable growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bass Oil Limited (BAS) ORDINARY FULLY PAID |
Energy |
$22 |
Operations Update - January 2026
|
27 Feb 2026 9:30AM |
$0.050 |
$0.059 |
risen by
18%
|
|
BAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Total sales revenue for January was A$471,374 net to Bass.
- Daily oil production for the group averaged 237 bopd for the month.
- Total Cooper Basin monthly production was 2,746 barrels.
- Total Indonesian oil production was 4,596 barrels net to Bass.
- Vanessa acquisition was approved by the regulator.
- Bass secured $3.5 million grant funding for Kiwi gas field development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Raiz Invest Limited (RZI) ORDINARY FULLY PAID |
Financials |
$61 |
Strong Revenue Growth,Improved Profitability & Positive NPAT
|
27 Feb 2026 9:30AM |
$0.605 |
$0.580 |
fallen by
4.13%
|
|
RZI - Price-sensitive ASX Announcement
Full Release
Key Points
- Raiz Invest Limited reported a strong 23.9% revenue growth for the half-year ended 31 December 2025.
- Funds Under Management (FUM) increased by 28.5% to $2.1 billion.
- Raiz achieved a Net Profit After Tax (NPAT) of $3.52 million, transitioning from a previous loss.
- The company's operating cash flows increased by 51.4% to $2.36 million.
- Underlying EBITDA increased by 270% to $2.6 million.
- Raiz's active customer base grew by 5.7% to 336,048.
- Raiz introduced new product offerings like the low-cost Raiz Lite Plan and expanded its product roadmap for 2026.
- The company maintained strategic partnerships to enhance product offerings and entered new partnerships to promote financial education.
- Raiz's Plus Plan portfolios increased by 33.6%, reflecting strong market acceptance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Platinum Asia Fund (Quoted Managed Hedge Fund) (PAXX) |
Financials |
$306 |
2026 Interim Financial Report
|
27 Feb 2026 9:29AM |
$6.460 |
$6.290 |
fallen by
2.63%
|
|
| GLG Corp Limited (GLE) ORDINARY FULLY PAID |
Consumer Discretionary |
$11 |
Half Year Financial Report and Appendix 4D
|
27 Feb 2026 9:29AM |
$0.115 |
$0.145 |
risen by
26.09%
|
|
GLE - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 18.7% to US$54.1m.
- Gross profit margin improved from 17.7% to 18.9%.
- Net loss after tax was US$0.5m compared to a profit of US$0.4m in the previous period.
- No interim dividend recommended for the period ended 31 December 2025.
- Finance costs increased by 10.1% due to higher working capital requirements.
- Cash and cash equivalents decreased slightly by US$0.2m.
- Trade and other receivables decreased by 9.5%.
- Inventory decreased by 14.8% due to lower customer orders.
- Administrative expenses fell by 8.4% through cost control measures.
- Management focuses on working capital optimization and liquidity preservation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| One Click Group Limited (1CG) ORDINARY FULLY PAID |
Industrials |
$13 |
Appendix 4E and Annual Report to Shareholders
|
27 Feb 2026 9:27AM |
$0.009 |
$0.010 |
risen by
11.11%
|
|
1CG - Price-sensitive ASX Announcement
Full Release
Key Points
- Consolidated revenue increased from $4.88 million in 2024 to $6.12 million in 2025.
- The company reported a net loss after tax of $716,460 for 2025 compared to a loss of $1.98 million in 2024.
- Total assets for 2025 stood at $4.67 million, slightly higher than $4.53 million in 2024.
- The company's equity increased to $3.64 million in 2025 from $2.94 million in 2024.
- Significant shareholdings and options details include various family accounts and trusts holding substantial percentages.
- Directors and key management personnel hold significant options and performance rights.
- The company engaged in share-based payments and financial transactions to manage equity and reserves.
- Employee expenses and other operational costs were reported with specific focus on superannuation and other benefits.
- The company did not engage in any on-market buy-back activities during the year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$37 |
Update - Notification of buy-back - MEC
|
27 Feb 2026 9:27AM |
$1.195 |
$1.210 |
risen by
1.26%
|
|
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$63 |
Section 708A Cleansing Statement
|
27 Feb 2026 9:27AM |
$0.100 |
$0.085 |
fallen by
15%
|
|
| Future Generation Australia Limited (FGX) ORDINARY FULLY PAID |
Financials |
$559 |
Appendix 4E and Annual Report
|
27 Feb 2026 9:26AM |
$1.420 |
$1.360 |
fallen by
4.23%
|
|
FGX - Price-sensitive ASX Announcement
Full Release
Key Points
- Future Generation Australia's investment portfolio grew by 14.1% in 2025, outperforming the S&P/ASX All Ordinaries Accumulation Index by 3.5%.
- The company's pre-tax net tangible assets (NTA) increased by 12.9% for the year ending 31 December 2025.
- Future Generation Australia paid 7.1 cents per share in fully franked dividends during 2025.
- A social investment of 1.0% was a significant difference between the investment portfolio performance and NTA performance.
- The company has a profits reserve of 43.9 cents per share before the payment of the final dividend.
- Future Generation Australia returned over $298.0 million or 81.6 cents per share in dividends and franking credits since inception.
- The company focuses on supporting vulnerable children aged 0 to 14 years and their caregivers.
- Future Generation Australia has partnerships with 11 not-for-profit organizations for social impact.
- Total allocation to social impact partners in 2025 was $4,063,802.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 6K Additive, Inc (6KA) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Materials |
$139 |
Appendix 4E and Annual Report
|
27 Feb 2026 9:26AM |
$0.875 |
$0.800 |
fallen by
8.57%
|
|
6KA - Price-sensitive ASX Announcement
Full Release
Key Points
- 6K Additive, Inc issued common stock as part of an IPO, with a significant number of shares allocated to 6K Inc and various nominees.
- The company reported a net loss of over $17 million for the year ended 31 December 2025.
- Revenue primarily came from product sales, with a small contribution from service revenue.
- 6K Additive conducted an IPO and various equity transactions during the year, resulting in changes in the shareholding structure.
- The company incurred significant costs in operating expenses, including selling, general, administrative, and research and development expenses.
- Intangible assets and goodwill were evaluated, with developed technology and customer relationships being major components.
- Equity-based compensation and stock options were part of the employee remuneration strategy.
- There were notable changes in cash flows from operating, investing, and financing activities, with a focus on IPO proceeds and equipment purchases.
- The company maintained a diverse shareholder base, with substantial holdings by 6K Inc and institutions like HSBC Custody Nominees and CITICORP.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacific Current Group Limited (PAC) ORDINARY FULLY PAID |
Financials |
$310 |
Update - Notification of buy-back - PAC
|
27 Feb 2026 9:25AM |
$10.020 |
$10.660 |
risen by
6.39%
|
|
| Shine Justice Ltd (SHJ) ORDINARY FULLY PAID |
Consumer Discretionary |
$123 |
FY26 Half-Year Results Presentation
|
27 Feb 2026 9:25AM |
$0.720 |
$0.725 |
risen by
0.69%
|
|
SHJ - Price-sensitive ASX Announcement
Full Release
Key Points
- Return to profitability with NPAT of $6.7 million compared to a $1.7 million loss in H1 FY25.
- Revenue growth driven by personal injury segment, achieving a year-on-year increase of approximately 8%.
- Interim fully franked dividend of 1.5 cents declared, payable on 24 April 2026.
- Gross operating cash flow was negative $6.3 million due to court and administrative delays in class action receipts.
- Strategic emphasis on emerging technology to improve case outcomes and operational efficiency.
- More than $600 million in damages achieved for over 2,000 clients in H1 FY26.
- Strong pipeline of class actions with significant potential settlements expected in H2.
- Focus on operational efficiency with stable employee expenses and overheads despite inflationary pressures.
- Expansion of work in progress (WIP) by $17.7 million, supporting future cash inflow potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| National Australia Bank Limited (NAB) ORDINARY FULLY PAID |
Financials |
$122,949 |
Appendix 3Y - Change of Director's Interest Notice
|
27 Feb 2026 9:24AM |
$49.040 |
$40.080 |
fallen by
18.27%
|
|
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$62 |
$5.5 million Secured for RHYO Options
|
27 Feb 2026 9:24AM |
$0.220 |
$0.175 |
fallen by
20.45%
|
|
| Lindian Resources Limited (LIN) ORDINARY FULLY PAID |
Materials |
$1,627 |
Trading Halt
|
27 Feb 2026 9:24AM |
$0.530 |
$0.890 |
risen by
67.92%
|
|
LIN - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Lindian Resources Limited (ASX: LIN).
- Halt due to pending announcement regarding a material acquisition.
- Trading halt to be lifted by 3 March 2026 or upon announcement release.
- Request made under ASX Listing Rule 17.1.
- No known reasons to deny the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| nanollose Limited (NC6) ORDINARY FULLY PAID |
Health Care |
$29 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:23AM |
$0.072 |
$0.082 |
risen by
13.89%
|
|
NC6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Nanollose Limited reported a loss of $1,526,079 for the half-year ended 31 December 2025, up 110% from the previous year.
- The company did not generate any revenue during this period.
- Net tangible assets were negative at -$169,751.
- No dividends were declared or paid for the current or previous period.
- A firm commitment was secured from Fiftyone Capital to raise $750,000 through option exercises.
- Nanollose progressed its Nullarbor lyocell fibre technology with a successful pilot production.
- The company's financial challenges include liquidity constraints and increased operational expenses.
- Directors are optimistic about strategic growth opportunities in upcoming quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dimerix Limited (DXB) ORDINARY FULLY PAID |
Health Care |
$228 |
Dimerix Presents at Oppenheimer Life Sciences Conference
|
27 Feb 2026 9:23AM |
$0.455 |
$0.380 |
fallen by
16.48%
|
|
Call 1300 880 160
Start a chat
Schedule a call
